Finance

Lists
OXB:LON
Oxford BioMedica plc
GBX 520.00
-1.52%
(-8.00) 1D
Oct 8, 4:24:33 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for OXB...
Open
GBX 515.00
High
GBX 537.00
Low
GBX 512.00
Mkt. cap
643.37M
Avg. vol.
819.23K
Volume
317.97K
52-wk high
GBX 962.00
52-wk low
GBX 420.00
EPS
-GBX 0.34
Shares outstanding
121.05M
No. of employees
1K
Open
GBX 515.00
High
GBX 537.00
Low
GBX 512.00
Mkt. cap
643.37M
Avg. vol.
819.23K
Volume
317.97K
52-wk high
GBX 962.00
52-wk low
GBX 420.00
EPS
-GBX 0.34
Shares outstanding
121.05M
No. of employees
1K
News stories
From web sources and news partners
Profile
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Wikipedia
About Oxford BioMedica plc
CEOFrank Mathias
Employees1.02K
Founded1995
Headquarters-
SectorBiotechnology
Websiteoxb.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
47.76M
47.76M
39.92M
39.92M
Cost of goods sold
30.60M
30.60M
25.35M
25.35M
Cost of revenue
30.60M
30.60M
25.35M
25.35M
Research and development expenses
1.54M
1.54M
1.14M
1.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.65M
19.65M
24.36M
24.36M
Operating expense
20.93M
20.93M
25.29M
25.29M
Total operating expenses
51.52M
51.52M
50.64M
50.64M
Operating income
-3.76M
-3.76M
-10.72M
-10.72M
Other non operating income
-323.00K
-323.00K
-141.50K
-141.50K
EBT including unusual items
-2.95M
-2.95M
-18.11M
-18.11M
EBT excluding unusual items
-7.26M
-7.26M
-14.29M
-14.29M
Income tax expense
-1.07M
-1.07M
372.00K
372.00K
Effective tax rate
36.20%
36.20%
-2.05%
-2.05%
Other operating expenses
-259.50K
-259.50K
-212.50K
-212.50K
Net income
-1.88M
-1.88M
-18.48M
-18.48M
Net profit margin
-3.94%
-3.94%
-46.29%
-46.29%
Earnings per share
-
-
-
-
Interest and investment income
649.50K
649.50K
917.00K
917.00K
Interest expense
-3.55M
-3.55M
-3.94M
-3.94M
Net interest expenses
-2.90M
-2.90M
-3.02M
-3.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.06M
-2.06M
-7.43M
-7.43M
Gain or loss from assets sale
53.00K
53.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps